Prospective Analysis Of Statin Use and Risk Of Non-Hodgkin’s Lymphoma In The Women’s Health Initiative Cohort
Desai P, Wallace R, Anderson M, et al.
Key Points:
Results of prospective analyses of Women’s Health Initiative (WHI) data assessing relationship between statins and risk of NHL reported
Statin intake decreased risk of development of NHL by 33% (HR= 0.66 (95% CI: 0.48-0.90), particularly DLBCL subtype
Compared with lipophilic statins, risk of developing NHL significantly lower with hydrophilic statin
Implications:
Data provide additional rationale for recommending statin for women aged 50-79 years
Additional Comments:
Additional prospective studies warranted to confirm this benefit
View the original abstract on the ASH website.
